Affiliation:
1. Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida.
Abstract
Summary
Plasma proteomic profiling to identify associations with myeloid neoplasm (MN) risk highlights the potential of integrating proteins and genetic biomarkers for the detection of individuals at high risk of developing MN. These proteins also offer valuable insights into biological pathways and inflammatory mechanisms involved in the progression of clonal hematopoiesis to MN.
See related article by Tran et al., p. 3220
Funder
Doris Duke Charitable Foundation
Edward P. Evans Foundation
National Institute of General Medical Sciences
Publisher
American Association for Cancer Research (AACR)